Delivery Order SPE2DB20D1100-SPE2DB25FC0W0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,574.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 9, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $9,656.92 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3 ml quantities. The contract represents a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,433.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25–0.5 mg/dose pens (3 mL) with an ultimate completion date of September 8, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $27,396.14 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,370.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) under contract number 4568429801. This non-competitive delivery order, awarded on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a supply of this diabetes medication to support federal healthcare needs. The contract was fulfilled by AmerisourceBergen's corporate office, with performance occurring at...
- The Defense Logistics Agency awarded a $13,578.99 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) with a completion date of September 15, 2025. This is a firm fixed-price, non-set-aside contract awarded on September 12, 2025, with fulfillment based at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $12,273.77 for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) under a firm fixed-price contract with an ultimate completion date of July 31, 2025. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $5,574.45 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $37,417.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3 mL formulations, with completion targeted for September 15, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a delivery order valued at $216,305.76 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 18, 2025, with completion targeted for September 19, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC0W0Delivery Order
The Defense Logistics Agency awarded a $15,368 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on May 2, 2025, with completion targeted for May 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal military and healthcare systems through the DLA Medical Supply Chain. The delivery order for this diabetes medication is consistent with the company's extensive portfolio of brand-name and generic pharmaceutical products supplied to support Defense Health Agency and other government healthcare programs. As a prime vendor under the DLA's comprehensive global pharmaceutical support vehicle, AmerisourceBergen regularly fulfills orders for medications across multiple therapeutic domains, demonstrating its capability to meet federal medical procurement requirements through competitive contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 5/2/25 |